Seattle, WA (LifeNews.com) -- A biotech firm has announced it will offer ethical alternatives to some of the vaccines that currently rely on the use of fetal tissue form abortions. The Seattle-based AVM Biotechnology says it will produce ethical alternatives in the fields of biotechnology, pharmaceuticals, and vaccine development.

The news gives hope to pro-life people who have been reluctant to use some vaccines because their development came as a result of the destruction of unborn children.

We will be working to bring commercially available, morally acceptable, vaccines to the US market and to use existing technology to produce new morally certified vaccines," says Dr. Theresa Deisher, the research and development director for AVM.

"Revenues from the vaccine business will also further the research, development and commercialization of morally certified therapeutics in other areas of medicine as well," she added.

The news was a pleasant surprise for Children of God for Life, a pro-life organization that has spent more than a decade highlighting the connection between some vaccines and abortion.

To help ensure that the biotech firm's vaccines do not have any abortion connection, the firm has placed Vinnedge on its Advisory Board for vaccine development.

While most vaccines and medicines are produced in an ethical manner, several are manufactured using cell lines derived from tissue obtained from babies who are victims of abortion. In some cases, Vinnedge notes, no ethical versions are available.

For too long parents who want to protect their children without compromising their deeply held pro-life and religious beliefs have been coerced into an unnecessary and unjust moral dilemma, she explained. No one should be forced to choose between these two fundamental human rights.

Vinnedge told LifeNews.com she hopes the news will be a further catalyst in getting members of Congress to support the Fair Labeling and Informed Consent act.

That's a bill that would require full disclosure from the pharmaceutical industry whenever aborted fetal or embryonic cell lines are used in medical products.

Every consumer, whether pro-life in philosophy or not, has the right to know if human fetal cell contaminants are present in the drugs they receive," Dr. Deisher noted.

Consumers should be informed and empowered to make the best health care choices for themselves and their families. Surely, if we have the right to know what is in our fast food, we should also have the right to know what is in our medicine," the researcher added.

Many of you have followed our efforts over the past 8 years. You have helped us immensely by getting the word out to the public about the use of aborted fetal cell lines in vaccines by distributing our materials at pro-life events, to friends and family and especially through your prayers. Some have also made donations as they could. I know all of you have waited patiently for the news I am sharing with you today - news that is sure to fill every one of you with much joy and hope for our future.

I’m sure there will be many questions in the coming weeks and months - how, when, where - and you can be assured I will keep you all updated as we progress. For now I would simply ask that you say a special prayer in thanksgiving and for the success of AVM Biotechnology.
God bless you always,

(Seattle) In a victory for pro-life families around the world, AVM Biotechnology LLC (AVM Biotech) today announced their decision to provide ethical alternatives in the fields of biotechnology, pharmaceuticals, and vaccine development.

Dr Theresa Deisher, AVM Biotech Research and Development Director and founder stated, We will be working to bring commercially available, morally acceptable, vaccines to the US market and to use existing technology to produce new morally certified vaccines. Revenues from the vaccine business will also further the research, development and commercialization of morally certified therapeutics in other areas of medicine as well.

The announcement was an answer to years of hard work and prayers for Children of God for Life, a pro-life organization that has battled to bring moral alternatives to aborted fetal vaccines to the US market for nearly a decade.

There are no words sufficient to express our deepest gratitude to Dr Deisher and AVM Biotech, noted the groups Executive Director, Debi Vinnedge, who was also named to AVM Biotechs Advisory Board for vaccine development.

While most vaccines and medicines are produced in an ethical manner, several are manufactured using cell lines derived from aborted fetal tissue with no competing ethical products available. Vinnedge noted this has left concerned pro-life families in both a difficult and unjust position.

For too long parents who want to protect their children without compromising their deeply held pro-life and religious beliefs have been coerced into an unnecessary and unjust moral dilemma, she stated. No one should be forced to choose between these two fundamental human rights.

Both organizations hope that the news will spark members of Congress to move forward with their Fair Labeling and Informed Consent legislation, a bill that would require full disclosure from the pharmaceutical industry whenever aborted fetal or embryonic cell lines are used in medical products.

Every consumer, whether pro-life in philosophy or not, has the right to know if human fetal cell contaminants are present in the drugs they receive, noted Dr Deisher. Consumers should be informed and empowered to make the best health care choices for themselves and their families. Surely, if we have the right to know what is in our fast food, we should also have the right to know what is in our medicine.”

AVM Biotech intends to further assist in this effort by certifying that its therapeutic products are not discovered, screened, evaluated, produced, or tainted in any way by the use of electively aborted human fetal material, human embryonic material, or any other unethically obtained materials.

most vaccines contain a toxic metal, mercury under the name of thimerosal, mercury is not allowed in school labs anywhere in the USA and we wonder why children get seizures, add, ADHD, asthma and other diseases after immunizations.

U.S. Vaccine AlternativesNOTE: No alternatives for Chickenpox, Rubella, Hepatitis-A, Ebola or HIV in U.S.

Disease

Vaccine Name

Manufacturer

Cell line

Polio

IPOL

Aventis-Pasteur

Monkey kidney cells

Mumps

Mumpsvax

Merck & Company

Chick embryo

Rabies

RabAvert

Chiron Therapeutics

Chick embryo

Measles

Attenuvax

Merck & Company

Chick Embryo

Smallpox

Acambis 2000

Acambis-Baxter

Vero (Monkey)

Smallpox

MVA

Acambis-Nordis Bav.

Chick Embryo

Flu

FluVirinFluShieldFluZone

ChironWyeth AyerestAventis Pasteur

Chick embryo

Flu

FluBlok

Protein Sciences

Caterpillar cell line

Vaccine Alternatives Available In The United Kingdom NOT FDA APPROVED FOR USE IN THE UNITED STATES

Disease

Brand name

Company

Cell line

Rubella

Takahashi Strain

Kitasato Institute

Rabbit kidney

Hepatitis A

Aimmugen

Chemo-therapeutic Institute Japan (Kaketsuken)

Monkey kidney

We are currently working in conjunction with the Foreign Manufacturersto obtain these vaccines in the United States.

The Rubella vaccine, produced by Merck & Company was taken from an aborted baby during the 1964 rubella epidemic when some mothers were advised to have abortions, rather than risk their child being born with Congenital Rubella Syndrome. It was from the 27th baby aborted and immediately dissected that the active rubella virus was finally found. It was commonly referred to as RA27/3, where R=Rubella, A=Abortus, 27=27th fetus, 3=third tissue culture explant. The abortionist collaborated with the Wistar Institute to collect the aborted babies in order to isolate the virus. The vaccine virus was then cultivated in the lung tissue of another aborted female baby, approximately 3 months gestation. (WI-38) (Attenuation of RA27/3 Rubella Virus in WI-38 Human Diploid Cells, Plotkin, Stanley, et. al., American Journal of Disease of Childhood, 118:178-185, 1969.) This abortion was performed because "the parents felt they had too many children." (G. Sven, S. Plotkin and K. McCarthy, Gamma Globulin Prophylaxis; Inactivated Rubella Virus; Production and Biological Control of Live Attenuated Rubella Virus Vaccines, American Journal of Diseases of Children, vol. 118, August 1969).The new vaccine was developed in Philadelphia, Pa. and tested on orphans. (American Journal Diseases of Children, Vol. 110, Oct. 1965) Considering that there was already two licensed rubella vaccines on the market and considering that they could have done exactly what the Japanese did in order to isolate the rubella virus (they swabbed the throat of an infected child), it is obvious this vaccine was created in order to justify fetal tissue research. It is also important to note that Rubella is basically a harmless childhood disease that is only considered to have possible serious effects on the unborn child when a pregnant woman is exposed to the virus during her first trimester. Should this occur, 20-25% of these cases will develop some form of Congenital Rubella Syndrome, which may cause malformations of the heart, eyes or brain, deafness, or liver, spleen and bone marrow problems.

Other Sources: Christina Abel RN. Merck & Company

Additional Facts - Hepatitis A

Havrix, the vaccine used to treat Hepatitis-A, uses a virus strain (HM175) propagated in MRC-5 human diploid (lung) cells which were taken from a male fetus aborted at 14 weeks gestation. These cells are lysed to form a suspension which is purified through ultrafiltration and gel permeation chromatography. The method is referenced to a standard using an Enzyme Linked Immunosorbent Assay (E.L.I.S.A.) and is expressed in terms of units (E.L.U.)

Havrix contains a sterile suspension of inactivated virus strains. The adult dosage consists of not less than 1440 E.L.U. viral antigen, 0.5mg of aluminum as aluminum hydroxide and 0.5% of 2-phenoxyethanol as a preservative. Other excipients are amino acid supplement (0.3%) in a phosphate buffered saline solution, polysorbate 20 (0.05mg/ml), MRC-5 cell proteins not greater than 5mgg and traces of formalin, not greater than 0.1mg.

The Centers for Disease Control noted that the best way to control Hep-A is to practice good hygiene, as the disease is spread through contact with fecal matter. Also, the product inserts for both Havrix and Vaqta show that the vaccine itself is not without problems. Neither vaccine has been evaluated for its carcinogenic or mutagenic potential, or its potential to impair fertility. It is also not known whether the vaccine can cause fetal harm when administered to a pregnant woman.**********************************Source:Glaxo SmithKline, Merck Package Inserts; CDC

Additional Facts - Chickenpox

VARIVAX was developed with the use of aborted fetuses.It uses both the human cell lines, named WI-38 (Wistar Institute) and MRC-5 (Medical Research Council). The vaccine contains residual components oftheir DNA and protein. The cell lines were derived from the lung tissue of an aborted female at 3 months gestation and an aborted male at 14 weeks gestation.The cells of these fetuses were then developed in a lab culture to produce several vaccines.

VARIVAXalso contains MSG (monosodium glutamate) in 2 forms, according to Jack Samuels, an expert on MSG. According to the FDA, MSG is not advised for infants, children, or pregnant women or children of childbearing age, and people with affective (mental/emotional) disorders.

According to VARIVAX product literature, the vaccine contains gelatin and trace amounts of neomycin, and should not be given to people allergic to them; it should not be given to anyone with an immune disorder, or anyone receiving drugs which affect the immune system such as chemotherapy or steroids; it should not be given to people with untreated tuberculosis or certain other infections.

Studies show that up to 3% of VARIVAX recipients contract chicken pox from the vaccine, and that some chicken pox cases may be contracted from recently vaccinated children. Vaccine recipients may therefore pose a health risk to pregnant mothers or family members with chronic health problems or compromised immune systems.

Some studies suggest that chicken pox in a vaccinated child may be milder than in an unvaccinated child. However, some experts believe that this may be due to the vaccine suppressing the illness, which could actually signal a more serious underlying chronic condition. For example, Atypical measles is a disease that occurs only in people previously vaccinated for measles, and it is far more serious than regular measles. It is not yet known if atypical chicken pox cases will appear as a result of the use of VARIVAX.

The FDA VAERS' (Vaccine Adverse Events Reporting System) first year surveillance of VARIVAX included over 1,500 reports. 76 were serious adverse reactions that included 2 deaths. While a VAERS report does not prove a causal relationship between the vaccine and the death or disability that follows, the vaccine is highly suspect in all such reports.

The FDA has stated that fewer than 10% of serious adverse reactions and deaths following vaccines are reported; independent researchers cite lower rates. The federal government has paid families of vaccine killed and disabled children nearly $100 million in taxpayer dollars each year since 1986 through the National Vaccine Injury Compensation Program (NVCIP).

Disclaimer:
Opinions posted on Free Republic are those of the individual
posters and do not necessarily represent the opinion of Free Republic or its
management. All materials posted herein are protected by copyright law and the
exemption for fair use of copyrighted works.